About Apnar Pharma
Apnar Pharma is a company based in Chino (United States) founded in 2014. It operates as a B2B. The company has 95 employees as of March 31, 2024. Apnar Pharma has completed 1 acquisition, including Aurex Laboratories. Apnar Pharma operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Chino, United States
- Employees 95 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Apnar Pharma Private Limited
- Date of Incorporation 12 Dec, 2014
- Jurisdiction Padra, Gujarat, India
-
Annual Revenue
$3.22 M (USD)83.73as on Mar 31, 2024
-
Net Profit
$7.51 K (USD)-88.94as on Mar 31, 2024
-
EBITDA
$783.49 K (USD)81.75as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
95
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apnar Pharma
Detailed funding history for Apnar Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apnar Pharma
Apnar Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aurex Laboratories.
Investment portfolio details for Apnar Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug manufacturing for multiple therapeutic areas is conducted through R&D.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Apnar Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Apnar Pharma
Detailed financials for Apnar Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apnar Pharma Comparisons
Peer comparison for Apnar Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apnar Pharma
Apnar Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Apnar Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apnar Pharma
Complete news archive for Apnar Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apnar Pharma
Apnar Pharma was founded in 2014.
Apnar Pharma is headquartered in Chino, United States. It is registered at Chino, California, United States.
As of Mar 31, 2024, the latest employee count at Apnar Pharma is 95.
Annual revenue of Apnar Pharma is $3.22M as on Mar 31, 2024.
Apnar Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug production. Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Apnar Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Apnar Pharma has made 1 acquisition, including Aurex Laboratories.